X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results

Go back to X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
(NASDAQ: XFOR) Delayed: 4.22 +0.17 (4.20%)
Previous Close $4.05    52 Week High
Open $4.03    52 Week Low
Day High $4.28    P/E N/A 
Day Low $4.02    EPS
Volume 866,269